Probiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation
Brain Sciences · 21.03.2026 · 16 (3) · 340
DOI: 10.3390/brainsci16030340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 21.03.2026. Verfasst von Olga Murgina und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh 394018, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mikhail Syromyatnikov, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Background/Objectives: The gut–brain axis is increasingly recognized as a critical modulator of cognitive function. This study investigated the neurotoxic effects of combined exposure to bacterial lipopolysaccharide (LPS) and the antiretroviral drug zidovudine (ZDV) in a mouse model, and evaluated the protective potential of two probiotic interventions: Bacillus subtilis and a mixture of lactobacilli.
Methods
Cognitive function was assessed using the Morris water maze (MWM). Gut microbiota composition was analyzed by 16S rRNA sequencing, and intestinal morphology was examined histologically. Gene expression of neuroinflammatory markers and mitophagy-related genes in brain tissue was quantified by RT-PCR. Plasma levels of cell-free mitochondrial DNA (cf-mtDNA) were measured as a marker of mitochondrial damage.
Results
Combined LPS + ZDV exposure induced systemic inflammation, impaired spatial memory, damaged the intestinal mucosa, and caused dysbiosis characterized by an increase in pro-inflammatory Muribaculaceae. In the brain, LPS + ZDV significantly upregulated Tnfa expression, confirming neuroinflammation. Bacillus subtilis administration prevented cognitive deficits, maintained Tnfa at control levels, and significantly reduced Il1b and Il6 expression compared to the LPS + ZDV group. This was accompanied by activation of the PINK1/PTEN-dependent mitophagy pathway, prevention of cf-mtDNA release, and restoration of gut microbial diversity. In contrast, the Lactobacilli mixture not only failed to improve outcomes but was associated with exacerbated intestinal damage, more pronounced cognitive dysfunction, and no reduction in neuroinflammatory markers.
Conclusions
Combined exposure to LPS and ZDV induces gut–brain axis dysfunction characterized by neuroinflammation, cognitive impairment, intestinal damage, and dysbiosis. Bacillus subtilis effectively preserves cognitive function through activation of PINK1/PTEN-dependent mitophagy and suppression of neuroinflammation, highlighting its potential as a therapeutic candidate for cognitive impairments associated with gut–brain axis dysfunction. The contrasting effects of the lactobacilli mixture underscore the critical importance of strain-specificity in probiotic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh 394018, Russia.
- Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, Voronezh 394036, Russia.
- Laboratory of Innovative Preparations of Recombinant Proteomics, All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy, Voronezh 394087, Russia.
- Department of Experimental Pharmacology and Functioning of Living Systems, All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy, Voronezh 394087, Russia.
ORCID-Profile: Inna Burakova, Svetlana Pogorelova, Polina Morozova, Yulia Smirnova, Artem Gureev
Förderung
- Mikhail Syromyatnikov
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Murgina, O., Stafeeva, K., Karaulova, S., Vostrikova, A., Kononova, S., Chursina, D., Pozdeeva, S., Makogonova, A., Burakova, I., Pogorelova, S., Morozova, P., Smirnova, Y., Syromyatnikov, M., Shutikov, V., Mikhailov, E., & Gureev, A. (2026). Probiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation. Brain Sciences, 16(3), 340. https://doi.org/10.3390/brainsci16030340
Vancouver
Murgina O, Stafeeva K, Karaulova S, Vostrikova A, Kononova S, Chursina D, et al. Probiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation. Brain Sciences. 2026;16(3):340. doi:10.3390/brainsci16030340
BibTeX
@article{Murgina2026,
author = {Murgina, Olga and Stafeeva, Ksenia and Karaulova, Sofya and Vostrikova, Alena and Kononova, Sofya and Chursina, Daria and Pozdeeva, Svetlana and Makogonova, Anastasia and Burakova, Inna and Pogorelova, Svetlana and Morozova, Polina and Smirnova, Yulia and Syromyatnikov, Mikhail and Shutikov, Viktor and Mikhailov, Evgeny and Gureev, Artem},
title = {Probiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation},
journal = {Brain Sciences},
year = {2026},
volume = {16},
number = {3},
pages = {340},
doi = {10.3390/brainsci16030340}
}
EUVIMED